Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0000899243-22-038538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-14 | 2022-12-12 | BEAM | Ciaramella Giuseppe | Pres, CSO | S - Sale+OE | $42.70 | -51.0K | 110.8K | -32% | -$2.18M |
| DM | 2022-12-14 | 2022-12-12 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $1.81 | +26.9K | 133.8K | +25% | +$48.7K |
| DM | 2022-12-14 | 2022-12-12 | BEAM | Ciaramella Giuseppe | Pres, CSO | M - OptEx | $0.00 | -26.9K | 4,326 | -86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | S | D | 13,933 | $43.15 | 96,845 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.76 to $43.75, inclusive. |
| 2 | Common | Common Stock | 2022-12-12 | S | D | 5,383 | $43.87 | 91,462 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.76 to $44.06, inclusive. |
| 3 | Common | Common Stock | 2022-12-12 | S | D | 31,699 | $42.30 | 110,778 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.74 to $42.71, inclusive. |
| 4 | Common | Common Stock | 2022-12-12 | M | A | 8,652 | $4.22 | 142,477 | D | — | — | |
| 5 | Common | Common Stock | 2022-12-12 | M | A | 18,211 | $0.67 | 133,825 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-12-12 | M | D | 18,211 | $0.00 | 189,491 | D | $0.67 · — to 2028-05-08 | 18,211 Common Stock | (F6) 25% of the shares subject to the stock option vested on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-12-12 | M | D | 8,652 | $0.00 | 4,326 | D | $4.22 · — to 2029-02-13 | 8,652 Common Stock | (F7) The option award vests upon the achievement of a closing price hurdle following BEAM's initial public offering (which closing price hurdle has been achieved) in three equal installments on December 21, 2021, June 30, 2022 and December 31, 2022. |